首页> 外国专利> 'pharmaceutical preparation comprising clodronate as an active ingredient and microcrystalline cellulose as an excipient, manufacturing process and use of silicated microcrystalline cellulose in the manufacture of said pharmaceutical preparation'

'pharmaceutical preparation comprising clodronate as an active ingredient and microcrystalline cellulose as an excipient, manufacturing process and use of silicated microcrystalline cellulose in the manufacture of said pharmaceutical preparation'

机译:“包含氯膦酸盐作为活性成分和微晶纤维素作为赋形剂的药物制剂,制备方法和二氧化硅微晶纤维素在所述药物制剂的制备中的用途”

摘要

"PHARMACEUTICAL PREPARATION UNDERSTANDING CHLODRONATE AS AN ACTIVE INGREDIENT AND MICROCRYSTALLINE CELLULOSE AS AN EXCIPIENT, MANUFACTURING PROCESS AND USE OF SILICATED MICROCRYSTALLINE CELLULOSE IN THE MANUFACTURE OF THAT PHARMACEUTICAL PREPARATION". The object of the present invention is a pharmaceutical preparation for oral use, especially a tablet, which as an active ingredient contains a pharmacologically acceptable salt of dichloromethylene bisphosphonic acid, that is, a clodronate, especially disodium clodronate and which, as an excipient, contains silicated microcrystalline cellulose . Other objects of the invention are a process for the manufacture of said pharmaceutical preparation and the use of silicated microcrystalline cellulose for the manufacture of said pharmaceutical preparation.
机译:“将氯酸盐理解为一种活性成分的药物制剂,而将微晶纤维素作为一种赋形剂,制造过程以及在该药物制备过程中使用硅化微晶纤维素的用途”。本发明的目的是用于口服的药物制剂,特别是片剂,其作为活性成分包含二氯亚甲基双膦酸的药理学上可接受的盐,即氯膦酸盐,尤其是氯膦酸二钠,并且其作为赋形剂含有硅化微晶纤维素。本发明的其他目的是制备所述药物制剂的方法,以及二氧化硅微晶纤维素在制备所述药物制剂中的用途。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号